Discover how simple blood tests can predict immunotherapy success for esophageal cancer patients, revolutionizing personalized cancer treatment.
Explore the groundbreaking phase 1 dose-escalation study of linclatamig, a LY6G6D×CD3 T cell-engaging bispecific antibody for colorectal cancer treatment.
Explore how combining local tumor ablation with systemic immunotherapy creates a powerful synergistic effect against advanced melanoma, improving patient outcomes.
Explore how transgenic mouse models are revolutionizing Alzheimer's research and paving the way for new immunotherapies.
Discover how Interleukin-10-alveolar macrophage cell membrane-coated nanoparticles are revolutionizing asthma treatment by targeting inflammation and restoring immune balance.
Discover how the Melanoma Inflammation Index (MII) uses simple blood tests to predict immunotherapy success in melanoma patients, potentially revolutionizing treatment approaches.
Discover how immune infiltration is revolutionizing prostate cancer treatment by turning cold tumors hot and activating the body's natural defenses against cancer.
Discover how FTY720 reverses cardiac dysfunction in SR-BI/ApoE knockout mice through immunomodulation, offering new approaches for heart failure treatment.
Discover how mesothelioma patients' antibodies reveal public and private cancer antigens, paving the way for innovative immunotherapies.